Developer docs
API playgroundTry for free, no card

Search company profiles

Vein specialist NYC

Full company profile

uuid002xje5

Namestring
Vein specialist NYC
Legal namestring
Scheer Medical Wellness
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Scheer Medical Wellness, operating under the trade name NYC Stem Cells, is a New York City-based regenerative medicine practice founded by Dr. Alexandre Scheer, MD. The clinic provides autologous stem cell therapy (harvested from the patient's own bone marrow or adipose tissue) and exosome therapy derived from stem cells, delivered at a single midtown Manhattan facility at 39 West 38th Street. It treats a broad range of conditions including arthritis and orthopedic issues, back pain, neurodegenerative diseases (Parkinson's, Alzheimer's, MS), stroke recovery, diabetes, autoimmune diseases, autism, and anti-aging indications.

The underlying technology combines surgical extraction (iliac-crest bone marrow aspiration or liposuction-based adipose harvest), centrifugation-based cell processing, enzymatic concentration of adipose-derived stem cells, and combination with platelet-rich plasma before targeted injection. Exosome therapy adds stem-cell-derived extracellular vesicles processed through ultracentrifugation and programmed to communicate with target cells. The practice emphasizes a single-physician clinical model under Dr. Scheer's medical direction, supplemented by a COO, a DNP candidate, and a licensed acupuncturist.

The business model is direct-to-consumer and entirely cash-pay: stem cell and exosome procedures are not covered by health insurance as they are considered experimental, and the practice mitigates affordability friction through third-party financing partners LightStream and PatientFi. Go-to-market relies on organic content (blog, video library, research citations), social media (Facebook, Instagram), podcast appearances, and patient testimonials rather than paid institutional channels. The practice has no disclosed funding, no parent company, and operates as an independently owned private medical practice serving individual patients on a per-procedure basis.

Short descriptiontext

Scheer Medical Wellness (NYC Stem Cells) is a New York City regenerative medicine practice offering cash-pay autologous stem cell and exosome therapy for conditions ranging from arthritis and neurodegenerative disease to anti-aging, under Medical Director Dr. Alexandre Scheer.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell therapy, regenerative medicine, exosome therapy, autologous cell treatment, pain management
Industry3 codes
1Stem Cell Therapies (MSC/iPSC/HSC-derived)
CodeHLAAABAEPrimaryYes
2Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)
CodeHLAAABAJPrimaryNo
3Cartilage, Bone & Musculoskeletal Regeneration
CodeHLAAAGAHPrimaryNo
NAICS code1 code
  • Blood and Organ Banks621991
Product category
Regenerative Medicine
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Consultation and Treatment Services
TypeOne Time License
Description

Direct patient payments for medical consultations, stem cell therapy procedures, exosome therapy treatments, and related regenerative medicine services. Services are not covered by health insurance as stem cell therapy is considered experimental.

nycstemcells.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The company provides regenerative medicine treatments centered on autologous stem cell therapy and exosome therapy. Stem cells are harvested from the patient's own bone marrow (iliac-crest hip bone via needle insertion) or adipose tissue (liposuction from abdomen, thighs, buttocks, or hips), processed via centrifuge or enzyme exposure, and injected into targeted areas to repair damaged cells and tissues. Exosomes are extracted from stem cells, purified through ultracentrifugation, and programmed to communicate with target cells for anti-aging, wound healing, and disease modification applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 50+ patients with 5-star reviews reported positive treatment outcomes
+2 more records
Product overview1 text field

Scheer Medical Wellness operates as a cutting-edge regenerative medicine practice offering three interconnected treatment modalities: Autologous Stem Cell Therapy (using the patient's own adipose tissue or bone marrow-derived stem cells), Exosome Therapy (using stem cell-derived extracellular vesicles), and general Stem Cell Therapy. These treatments activate the body's natural healing mechanisms to repair damaged cells and tissues. The practice specializes in treating a wide range of conditions including arthritis, back pain, autoimmune diseases, neurodegenerative disorders (Parkinson's, Alzheimer's, MS), autism, diabetes, and stroke recovery. All treatments are administered at their New York City facility under the supervision of Medical Director Dr. Alexandre Scheer, MD.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeOthers
Description

Website development and digital marketing agency responsible for the practice's website design and maintenance.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare strategy organization where Kathleen Francesca serves as President. Kathleen also serves as COO of NY Stem Cells, creating a strategic connection in healthcare strategy and media.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Global wellness concierge platform founded by COO Kathleen Francesca, connecting clients to advanced medical, regenerative, and wellness solutions worldwide with presence in US, Latin America, and Asia.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1NSI Stem Cell
TypeDirect peer
Description

NSI Stem Cell operates multiple U.S. clinics delivering autologous adult stem cell therapy for a wide range of chronic conditions, using a similar direct-to-consumer marketing and pricing approach.

TypeDirect peer
Description

Regenexx operates a national network of clinics delivering autologous stem cell and platelet-rich plasma therapies for orthopedic and musculoskeletal conditions, with a direct-to-consumer cash-pay model similar to Scheer Medical Wellness.

TypeDirect peer
Description

BioXcellerator is a stem cell therapy clinic offering autologous and cultured stem cell treatments for orthopedic, neurological, and autoimmune conditions with a cash-pay, premium-care delivery model.

TypeDirect peer
Description

The Lung Institute is a cash-pay regenerative medicine clinic using autologous stem cell therapy for pulmonary and other chronic conditions, with similar direct-to-consumer marketing and self-pay patient dynamics.

TypeDirect peer
Description

StemGenex runs a stem cell treatment clinic offering autologous adipose- and bone marrow-derived therapies for a broad range of conditions including autoimmune, neurological, and orthopedic indications, mirroring Scheer's positioning.

TypeEmerging player
Description

Personalized Stem Cells develops FDA-IND-compliant autologous adipose-derived stem cell therapies with clinical trial programs, representing an emerging, more clinically rigorous counterpart in the same autologous therapy space.

TypeRegional player
Description

Park Avenue Stem Cell is a New York City-based regenerative medicine clinic offering autologous stem cell and PRP therapies; geographically overlapping with Scheer Medical Wellness in the Manhattan market.

TypeRegional player
Description

StemCells21 is a Bangkok-based regenerative medicine clinic offering autologous stem cell and exosome therapies to international medical-tourism patients, providing a comparable but geographically distinct treatment model.

TypeDirect peer
Description

Okyanos provides adult stem cell therapy using autologous adipose-derived cells for cardiac, orthopedic, and neurological conditions under a private-pay clinical model comparable to Scheer's practice.

TypeDirect peer
Description

Celltex Therapeutics provides autologous mesenchymal stem cell banking and therapy services, targeting similar regenerative medicine indications through a private-pay clinical delivery model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vein specialist NYC

Regenerative Medicinenycstemcells.com

Scheer Medical Wellness (NYC Stem Cells) is a New York City regenerative medicine practice offering cash-pay autologous stem cell and exosome therapy for conditions ranging from arthritis and neurodegenerative disease to anti-aging, under Medical Director Dr. Alexandre Scheer.

What Vein specialist NYC does

Scheer Medical Wellness, operating under the trade name NYC Stem Cells, is a New York City-based regenerative medicine practice founded by Dr. Alexandre Scheer, MD. The clinic provides autologous stem cell therapy (harvested from the patient's own bone marrow or adipose tissue) and exosome therapy derived from stem cells, delivered at a single midtown Manhattan facility at 39 West 38th Street. It treats a broad range of conditions including arthritis and orthopedic issues, back pain, neurodegenerative diseases (Parkinson's, Alzheimer's, MS), stroke recovery, diabetes, autoimmune diseases, autism, and anti-aging indications.

The underlying technology combines surgical extraction (iliac-crest bone marrow aspiration or liposuction-based adipose harvest), centrifugation-based cell processing, enzymatic concentration of adipose-derived stem cells, and combination with platelet-rich plasma before targeted injection. Exosome therapy adds stem-cell-derived extracellular vesicles processed through ultracentrifugation and programmed to communicate with target cells. The practice emphasizes a single-physician clinical model under Dr. Scheer's medical direction, supplemented by a COO, a DNP candidate, and a licensed acupuncturist.

The business model is direct-to-consumer and entirely cash-pay: stem cell and exosome procedures are not covered by health insurance as they are considered experimental, and the practice mitigates affordability friction through third-party financing partners LightStream and PatientFi. Go-to-market relies on organic content (blog, video library, research citations), social media (Facebook, Instagram), podcast appearances, and patient testimonials rather than paid institutional channels. The practice has no disclosed funding, no parent company, and operates as an independently owned private medical practice serving individual patients on a per-procedure basis.

Vein specialist NYC firmographics

Firmographics
Name
Vein specialist NYC
Legal name
Scheer Medical Wellness
Website
https://nycstemcells.com
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
51–100 employees
Short description
Scheer Medical Wellness (NYC Stem Cells) is a New York City regenerative medicine practice offering cash-pay autologous stem cell and exosome therapy for conditions ranging from arthritis and neurodegenerative disease to anti-aging, under Medical Director Dr. Alexandre Scheer.
Ownership category
akta.pro rank

Vein specialist NYC industry classification

Industry
Product category
Regenerative Medicine
NAICS
Blood and Organ Banks (621991)
akta.pro primary industry
Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)
akta.pro secondary industries
Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

Keywords

  • Stem cell therapy
  • Regenerative medicine
  • Exosome therapy
  • Autologous cell treatment
  • Pain management

Where Vein specialist NYC is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Vein specialist NYC business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Medical Consultation and Treatment Services: Direct patient payments for medical consultations, stem cell therapy procedures, exosome therapy treatments, and related regenerative medicine services. Services are not covered by health insurance as stem cell therapy is considered experimental.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Vein specialist NYC product offering

Product offering

Core offering

The company provides regenerative medicine treatments centered on autologous stem cell therapy and exosome therapy. Stem cells are harvested from the patient's own bone marrow (iliac-crest hip bone via needle insertion) or adipose tissue (liposuction from abdomen, thighs, buttocks, or hips), processed via centrifuge or enzyme exposure, and injected into targeted areas to repair damaged cells and tissues. Exosomes are extracted from stem cells, purified through ultracentrifugation, and programmed to communicate with target cells for anti-aging, wound healing, and disease modification applications.

Product overview

Scheer Medical Wellness operates as a cutting-edge regenerative medicine practice offering three interconnected treatment modalities: Autologous Stem Cell Therapy (using the patient's own adipose tissue or bone marrow-derived stem cells), Exosome Therapy (using stem cell-derived extracellular vesicles), and general Stem Cell Therapy. These treatments activate the body's natural healing mechanisms to repair damaged cells and tissues. The practice specializes in treating a wide range of conditions including arthritis, back pain, autoimmune diseases, neurodegenerative disorders (Parkinson's, Alzheimer's, MS), autism, diabetes, and stroke recovery. All treatments are administered at their New York City facility under the supervision of Medical Director Dr. Alexandre Scheer, MD.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 50+ patients with 5-star reviews reported positive treatment outcomes
  • +2 more outcomes

Companies that use Vein specialist NYC

Customer profile

Named customers9 records

Segments7 records

Ideal customer profiles1 record

Vein specialist NYC technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Vein specialist NYC partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

  • ON Digital AgencyminorOthersWebsite development and digital marketing agency responsible for the practice's website design and maintenance.
  • MedLuxe InstituteminorStrategic or Co-development PartnerHealthcare strategy organization where Kathleen Francesca serves as President. Kathleen also serves as COO of NY Stem Cells, creating a strategic connection in healthcare strategy and media.
  • Nouveau Wellness ConciergeminorStrategic or Co-development PartnerGlobal wellness concierge platform founded by COO Kathleen Francesca, connecting clients to advanced medical, regenerative, and wellness solutions worldwide with presence in US, Latin America, and Asia.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Vein specialist NYC competitors and assessment

Company assessment

Direct peers

  • NSI Stem Cell: NSI Stem Cell operates multiple U.S. clinics delivering autologous adult stem cell therapy for a wide range of chronic conditions, using a similar direct-to-consumer marketing and pricing approach.
  • Regenexx: Regenexx operates a national network of clinics delivering autologous stem cell and platelet-rich plasma therapies for orthopedic and musculoskeletal conditions, with a direct-to-consumer cash-pay model similar to Scheer Medical Wellness.
  • BioXcellerator: BioXcellerator is a stem cell therapy clinic offering autologous and cultured stem cell treatments for orthopedic, neurological, and autoimmune conditions with a cash-pay, premium-care delivery model.
  • The Lung Institute: The Lung Institute is a cash-pay regenerative medicine clinic using autologous stem cell therapy for pulmonary and other chronic conditions, with similar direct-to-consumer marketing and self-pay patient dynamics.
  • StemGenex: StemGenex runs a stem cell treatment clinic offering autologous adipose- and bone marrow-derived therapies for a broad range of conditions including autoimmune, neurological, and orthopedic indications, mirroring Scheer's positioning.
  • Okyanos Stem Cell Center: Okyanos provides adult stem cell therapy using autologous adipose-derived cells for cardiac, orthopedic, and neurological conditions under a private-pay clinical model comparable to Scheer's practice.
  • Celltex Therapeutics: Celltex Therapeutics provides autologous mesenchymal stem cell banking and therapy services, targeting similar regenerative medicine indications through a private-pay clinical delivery model.

Emerging players

  • Personalized Stem Cells: Personalized Stem Cells develops FDA-IND-compliant autologous adipose-derived stem cell therapies with clinical trial programs, representing an emerging, more clinically rigorous counterpart in the same autologous therapy space.

Regional players

  • Park Avenue Stem Cell: Park Avenue Stem Cell is a New York City-based regenerative medicine clinic offering autologous stem cell and PRP therapies; geographically overlapping with Scheer Medical Wellness in the Manhattan market.
  • StemCells21: StemCells21 is a Bangkok-based regenerative medicine clinic offering autologous stem cell and exosome therapies to international medical-tourism patients, providing a comparable but geographically distinct treatment model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Vein specialist NYC social profiles

Digital presence

Vein specialist NYC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vein specialist NYC leadership team

Management profile

Number of profiles

Profiles4 records

Vein specialist NYC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vein specialist NYC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vein specialist NYC

What does Vein specialist NYC do?

The company provides regenerative medicine treatments centered on autologous stem cell therapy and exosome therapy. Stem cells are harvested from the patient's own bone marrow (iliac-crest hip bone via needle insertion) or adipose tissue (liposuction from abdomen, thighs, buttocks, or hips), processed via centrifuge or enzyme exposure, and injected into targeted areas to repair damaged cells and tissues. Exosomes are extracted from stem cells, purified through ultracentrifugation, and programmed to communicate with target cells for anti-aging, wound healing, and disease modification applications.

Is Vein specialist NYC a public or private company?

Vein specialist NYC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Vein specialist NYC founded?

Vein specialist NYC was founded in 2005. It employs 51 to 100 people.

Where is Vein specialist NYC based?

Vein specialist NYC is headquartered in New York, United States, in the North America region.

How does Vein specialist NYC make money?

One revenue line is on record: medical Consultation and Treatment Services.

Who are Vein specialist NYC's main competitors?

Direct peers on record are NSI Stem Cell, Regenexx, BioXcellerator, The Lung Institute, StemGenex, Okyanos Stem Cell Center and Celltex Therapeutics. Personalized Stem Cells is listed as an emerging player. Regional players are Park Avenue Stem Cell and StemCells21.

Does Vein specialist NYC have an API?

No public API is recorded for Vein specialist NYC.

What industry is Vein specialist NYC in?

Vein specialist NYC's product category is Regenerative Medicine. Its primary akta.pro industry code is HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived), with a secondary code of HLAAABAJ, Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring). Its NAICS code is 621991.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales